Literature DB >> 24393848

The effect of Pokemon on bladder cancer epithelial-mesenchymal transition.

Changcheng Guo1, Kai Zhu2, Wei Sun3, Bin Yang4, Wenyu Gu5, Jun Luo6, Bo Peng7, Junhua Zheng8.   

Abstract

OBJECTIVE: This study aimed at detecting Pokemon expression in bladder cancer cell and investigating the relationship between Pokemon and epithelial-mesenchymal transition. Furthermore, we investigated the functions of Pokemon in the carcinogenesis and development of bladder cancer. This study was also designed to observe the inhibitory effects of siRNA expression vector on Pokemon in bladder cancer cell.
METHODS: The siRNA expression vectors which were constructed to express a short hairpin RNA against Pokemon were transfected to the bladder cancer cells T24 with a liposome. Levels of Pokemon, E-cadherin and β-catenin mRNA and protein were examined by real-time quantitative-fluorescent PCR and Western blot analysis, respectively. The effects of Pokemon silencing on epithelial-mesenchymal transition of T24 cells were evaluated with wound-healing assay.
RESULTS: Pokemon was strongly inhibited by siRNA treatment, especially siRNA3 treatment group, as it was reflected by Western blot and real-time PCR. The gene and protein of E-cadherin expression level showed increased markedly after Pokemon was inhibited by RNA interference. While there were no differences in the levels of gene and protein of β-catenin among five groups. The bladder cancer cell after Pokemon siRNA interference showed a significantly reduced wound-closing efficiency at 6, 12 and 24h.
CONCLUSIONS: Our findings suggest Pokemon may inhibit the expression of E-cadherin. The low expression of E-cadherin lead to increasing the phenotype and apical-base polarity of epithelial cells. These changes of cells may result in the recurrence and progression of bladder cancer at last.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; E-cadherin; Epithelial–mesenchymal transition; Pokemon; β-Catenin

Mesh:

Substances:

Year:  2014        PMID: 24393848     DOI: 10.1016/j.bbrc.2013.12.115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder.

Authors:  Changcheng Guo; Dabo Xiong; Bin Yang; Haiming Zhang; Wenyu Gu; Min Liu; Xudong Yao; Junhua Zheng; Bo Peng
Journal:  Oncol Lett       Date:  2017-08-24       Impact factor: 2.967

2.  MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.

Authors:  Min Zhu; Mingyang Li; Tao Wang; Enqiang Linghu; Benyan Wu
Journal:  Tumour Biol       Date:  2016-08-04

3.  Heterogeneous microenvironment analysis to explore the potential regulatory role of endothelial-mesenchymal transition in idiopathic pulmonary fibrosis.

Authors:  Yinning Xu; Xiaoping Hu; Yiwen Zhang; Zongfu Pan; Zhiyong Sun; Zhongjie Huang; Shuilian Zheng; Hansheng Pan; Xiaozhou Zou; Ping Huang
Journal:  Ann Transl Med       Date:  2022-04

Review 4.  Role of ZBTB7A zinc finger in tumorigenesis and metastasis.

Authors:  Atul Kumar Singh; Shiv Verma; Prem Prakash Kushwaha; Kumari Sunita Prajapati; Mohd Shuaib; Shashank Kumar; Sanjay Gupta
Journal:  Mol Biol Rep       Date:  2021-05-20       Impact factor: 2.316

5.  Cooperation of the BTB-Zinc finger protein, Abrupt, with cytoskeletal regulators in Drosophila epithelial tumorigenesis.

Authors:  Nezaket Turkel; Marta Portela; Carole Poon; Jason Li; Anthony M Brumby; Helena E Richardson
Journal:  Biol Open       Date:  2015-07-17       Impact factor: 2.422

6.  ZBTB7A, a miR-144-3p targeted gene, accelerates bladder cancer progression via downregulating HIC1 expression.

Authors:  Junqiang Liu; Zhiyuan Chou; Chun Li; Kai Huang; Xuejian Wang; Xiunan Li; Chuanchun Han; Abdullah Al-Danakh; Xiaodong Li; Xishuang Song
Journal:  Cancer Cell Int       Date:  2022-05-02       Impact factor: 6.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.